The WHO estimates that 422 million people worldwide suffer from diabetes, with the majority residing in low- or middle-income ...

Travelling can be thrilling and overwhelming, especially when you’re managing a chronic condition like diabetes. The idea of ...

South Africa's competition watchdog launches a crucial investigation into pharmaceutical giants Novo Nordisk and Sanofi over their insulin pen market practices, amid growing concerns about ...

Quality scores dipped during the COVID-19 pandemic, but are now at or above 2019 levels in areas such as diabetes and asthma management.

The American Diabetes Association released a statement ... including pre-filled insulin pens and vials. The company suggested that this would mean patients would pay $25-35 for their insulin.

Used sharps, including hypodermic needles for medical injections, require safe storage in an FDA-cleared container made of ...

President and CEO Ned McCoy shared with Becker's some of the company's key objectives for the year, including the launch of some of the first medications from its Petersburg, Va.-based plant, the ...

a new weekly formulation of established GLP-1 diabetes drug with the added benefit of glucose reduction, better weight loss results and a new injection pen. AstraZeneca announced that the EC green ...

Novo Nordisk’s semaglutide diabetes and weight loss drugs, Ozempic and Wegovy, are no longer officially in shortage in the US ...

Belarusian pharmaceutical companies produce about 1,800 medicines of various pharmacotherapeutic groups, and Belpharmprom Holding ...

Weight-loss jabs have become so popular that recent figures suggest that over half a million people are taking either ...